VivoSim Labs, Inc.
VIVS
$2.24
$0.052.28%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 35.92% | 94.52% | 32.11% | -49.59% | -72.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 35.92% | 94.52% | 32.11% | -49.59% | -72.01% |
| Cost of Revenue | -6.57% | -11.63% | -8.51% | -47.05% | -49.29% |
| Gross Profit | 7.48% | 13.13% | 9.33% | 46.98% | 48.39% |
| SG&A Expenses | -3.00% | -15.95% | -20.28% | -26.47% | -21.55% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.36% | -14.38% | -16.03% | -36.63% | -35.04% |
| Operating Income | 4.68% | 14.93% | 16.37% | 36.48% | 34.34% |
| Income Before Tax | 84.20% | 85.79% | 83.05% | 35.11% | 33.10% |
| Income Tax Expenses | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | 84.19% | 85.79% | 83.04% | 35.11% | 33.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.19% | 85.79% | 83.04% | 35.11% | 33.09% |
| EBIT | 4.68% | 14.93% | 16.37% | 36.48% | 34.34% |
| EBITDA | 4.53% | 15.05% | 16.59% | 37.02% | 34.68% |
| EPS Basic | 97.12% | 93.69% | 86.96% | 62.58% | 52.07% |
| Normalized Basic EPS | 50.61% | 58.49% | 57.36% | 62.89% | 52.36% |
| EPS Diluted | 97.12% | 93.69% | 86.96% | 62.58% | 52.07% |
| Normalized Diluted EPS | 50.61% | 58.49% | 57.36% | 62.89% | 52.36% |
| Average Basic Shares Outstanding | 95.77% | 17.84% | -19.22% | -39.49% | -53.77% |
| Average Diluted Shares Outstanding | 95.77% | 17.84% | -19.22% | -39.49% | -53.77% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |